The FDA declined to approve one of biotech’s most closely watched cancer drugs. The company’s stock tumbled.
Real-world example for IB, A-Level, AP and IGCSE Economics essays: Market power and competition policy, Information failure, Financial markets and banks
What happened
The FDA declined to approve Summit Therapeutics' closely watched lung-cancer drug, telling the company it must show the treatment helps patients live longer, and the company's stock fell sharply.
The economics
The case shows that regulatory approval is a key barrier shaping a pharmaceutical firm's market power: approval brings exclusive sales and pricing under patent protection, while rejection leaves potential market share unrealised. The demand for stronger efficacy evidence also reflects information asymmetry, since regulators require credible clinical data and investors reprice the firm based on approval signals.
Evaluation
The share-price fall reflects markets repricing approval risk in the short run, but long-run returns could recover if further trials succeed; strict approval protects patients yet may delay access to effective medicines.
Practice question
Using this example, discuss how government regulatory approval affects a pharmaceutical firm's market power and investment decisions.
Where it fits in the syllabus
- Market power and competition policy: When a few firms control a market they can raise prices; governments use antitrust and regulation to protect competition.
- Information failure: One side of a deal knows more than the other, so the market allocates resources badly.
- Financial markets and banks: How banks, bond and stock markets fund the economy, and what swings in asset prices do.
- IB Economics: Government Intervention and Market Failure, Fiscal and Monetary Policy
- A-Level Economics: Market Failure, Government Microeconomic Intervention, Economic Policy
- AP Macroeconomics: Financial Sector
- AP Microeconomics: Monopoly, Oligopoly and Monopolistic Competition, Market Failure and the Role of Government
- IGCSE Economics: Business Economics